Bioactive Peptide Market Poised to Witness High Growth Owing to Wide Applications in Functional Food and Dietary Supplements
![]() |
Bioactive Peptide Market |
The
bioactive peptide market is gaining strong traction owing to wide applications
in functional food and dietary supplements. Bioactive peptides are protein
fragments that have positive impacts on human health beyond their nutritional
value. They are derived from food proteins through enzymatic hydrolysis and
fermentation. These peptides help in reducing blood pressure, enhancing the
immune system, and improving metabolic functions. The growing preference for
functional foods targeted towards specific health conditions like immunity,
heart health, digestive function is driving the demand for bioactive peptides.
The Global
Bioactive Peptide Market Demand is estimated to be valued at US$ 11.29
Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period
of 2024 to 2030.
Bioactive
peptides offer several health benefits and help prevent lifestyle diseases.
Innovation in techniques to develop novel bioactive peptides and their wide
inclusion in food and supplement formulations is boosting the market growth.
Rising consumer awareness about bioactive peptides and clean label trends are
also supporting market expansion.
Key Takeaways
Key players operating in the bioactive peptide market are Archer Daniels
Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd.,
Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy,
GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC,
vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO
Forschung und Entwicklung GmbH, and BIONANOPLUS.
Key opportunities in the market include expanding applications of bioactive
peptides in cosmeceuticals, developing hydrolysis techniques for new bioactive
peptides, and tapping growth opportunities in emerging markets like Asia
Pacific and Latin America. Major players are focusing on strategic
collaborations and new product launches to expand their global footprint.
Market drivers include increasing demand for functional foods and dietary
supplements, growing health consciousness among consumers, and rising
prevalence of lifestyle diseases like hypertension, diabetes, and obesity which
is fueling demand for preventive healthcare solutions. Market restraints
include high R&D costs associated with bioactive peptide development and
commercialization challenges due stringent regulations.
Market Drivers:
- Growing demand for functional foods and dietary supplements: Functional foods
and supplements containing bioactive peptides have witnessed increasing demand
from health-conscious consumers for their health benefits. Rising awareness
about benefits of bioactive peptides in preventing diseases is driving the growth.
- Rising prevalence of lifestyle diseases: Growing prevalence of chronic
conditions like hypertension, cardiovascular diseases, diabetes and obesity due
to changing lifestyles and dietary patterns are fueling the demand for
preventive healthcare and wellness solutions like bioactive peptides.
Market Restrains:
- High R&D costs: Development of novel bioactive peptides involves
extensive R&D and clinical trials which increases the costs. This acts as a
restraint for small players to enter the market.
- Regulatory challenges: Commercialization of bioactive peptides faces
regulatory challenges as they are considered as novel ingredients. Stringent
safety evaluation and approval procedures delay market entry and increase
costs.
Segment Analysis
The bioactive peptide market is dominated by collagen peptides sub segment.
Collagen peptides are increasingly popular in dietary supplements, functional
foods and cosmetics. Collagen is the major structural protein required for
healthy skin, bones, muscles and joints. With growing aged population and
health awareness, collagen peptides are in high demand for joint and bone
health. Collagen peptides are easily absorbable and provide benefits of
collagen protein without any side effects. This makes collagen peptides ideal
for wide range of consumers and most popular among bioactive peptides.
Global Analysis
North America dominates the bioactive peptide market owing to factors such
growing health awareness, increased spending on healthcare and dietary
supplements. Aged population rate is rising rapidly in the US and Canada thus
fuelling demand for bioactive peptides for joint and bone health. Europe is the
second fastest growing market driven by demand from Germany, UK and France.
Asia Pacific is emerging as lucrative market with China and India as major
revenue generators. Rising middle class, growing economies and rising
healthcare expenditure are driving bioactive peptide market growth in Asia
Pacific region. Latin America and Middle East & Africa markets are projected
to witness steady growth during forecast period.
Get more insights on: Bioactive
Peptide Market
Comments
Post a Comment